Skip to Main Content

Paper Details

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses.
Emerg Microbes Infect
22
2022
2-36, ACE2, Antibody 2-36, COVID-19, K378T, SARS, SARS-COV, SARS-CoV, SARS-CoV spike, SARS-CoV-2, SARS-CoV-2 RBD, SARS-related coronaviruses, bat, human, human angiotensin-converting enzyme 2, patients, sarbecovirus, sarbecoviruses
Author NameAffiliation
Peter D KwongColumbia University
Peter D KwongVaccine Research Center, National Institutes of Health
Lawrence ShapiroAaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons
Lawrence ShapiroColumbia University
Lawrence ShapiroAaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons
Lawrence ShapiroColumbia University
  • 1 - 6

Datasets

Release 1.2